Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Targeted Therapies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01566019
What this trial is testing

Molecular Screening for Cancer Treatment Optimization

Who this might be right for
Metastatic Solid Tumors (Any Localization)
Gustave Roussy, Cancer Campus, Grand Paris 2,150
Not applicableLooking for participantsNCT07498933
What this trial is testing

FAP-targeted PET/NIR in Lung Malignant Tumors

Who this might be right for
Non-Small Cell Lung CancerPET/CTNeoadjuvant Therapy
Peking University People's Hospital 200
Large-scale testing (Phase 3)Looking for participantsNCT05770544
What this trial is testing

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.

Who this might be right for
Haematological MalignancyMalignancyMalignant Neoplasm+8 more
Cancer Research UK 30
Large-scale testing (Phase 3)Looking for participantsNCT06988475
What this trial is testing

DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations

Who this might be right for
Solid TumourHaematological MalignancyMalignant Neoplasm+8 more
Cancer Research UK 30
Not applicableLooking for participantsNCT07058454
What this trial is testing

Multicenter Prospective Observational Study of Cardiotoxicity in Patients Receiving Targeted Cancer Therapies

Who this might be right for
Cancer;Cardiovascular;Adverse EventsCancer
Sixth Affiliated Hospital, Sun Yat-sen University 5,000
Not applicableUnknownNCT05058937
What this trial is testing

Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre

Who this might be right for
Solid TumorMetastatic Cancer
The Belgian Society of Medical Oncology 936
Testing effectiveness (Phase 2)Study completedNCT02094872
What this trial is testing

Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
Yale University 49
Not applicableActive Not RecruitingNCT03835520
What this trial is testing

Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy

Who this might be right for
Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07802418
What this trial is testing

Molecularly Tailored Therapy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Herlev Hospital 1,200
Not applicableActive Not RecruitingNCT04584008
What this trial is testing

Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics

Who this might be right for
Biliary Tract NeoplasmsGastric CancerEsophageal Squamous Cell Carcinoma+6 more
Peking University 600
Testing effectiveness (Phase 2)Ended earlyNCT02414750
What this trial is testing

Vemurafenib Plus Cobimetinib in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Netherlands Working Group on Immunotherapy of Oncology 78
Not applicableStudy completedNCT07302932
What this trial is testing

Metformin and Molecular Aging in Prediabetes

Who this might be right for
Metformin, Prediabetes
Diabetes Foundation, India 112
Testing effectiveness (Phase 2)WithdrawnNCT00343759
What this trial is testing

Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted Therapy

Who this might be right for
Breast Cancer
University of Pennsylvania
Testing effectiveness (Phase 2)Ended earlyNCT00671645
What this trial is testing

Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy

Who this might be right for
Rectal Cancer
Austrian Breast & Colorectal Cancer Study Group 8
Large-scale testing (Phase 3)Looking for participantsNCT05615818
What this trial is testing

Personalized Medicine for Advanced Biliary Cancer Patients

Who this might be right for
Biliary Tract Neoplasms
UNICANCER 800
Early research (Phase 1)Study completedNCT04959981
What this trial is testing

Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC

Who this might be right for
Advanced Non-squamous Non-small-cell Lung Cancer
Erasca, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT01771458
What this trial is testing

Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients With Refractory Cancer

Who this might be right for
Reccurent/Metastatic Solid Tumor Disease
Institut Curie 742
Not applicableStudy completedNCT07256184
What this trial is testing

Prognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center Analysis

Who this might be right for
Metastatic Malignant Melanoma
Ankara Etlik City Hospital 232
Early research (Phase 1)Looking for participantsNCT06983743
What this trial is testing

ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Erasca, Inc. 600
Not applicableLooking for participantsNCT05701787
What this trial is testing

Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations

Who this might be right for
NSCLCNSCLC Stage IVNSCLC, Recurrent
Shanghai Chest Hospital 500
Next Page